unknown
Stage
About
Develops an AI-driven synthetic biology platform to design novel control mechanisms that improve the safety of gene and cell therapies. Partners with biopharma organisations to optimise and expand the applications of gene therapies.
Explore Concinnity Genetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.